Tirzepatide demonstrated remarkable weight-reducing efficacy in randomized controlled trials such as SURMOUNT-1 and SURMOUNT-2, with mean body-weight reductions ranging from 15 to 22.5% ( 4.3 Modulation of inflammatory status by tirzepatide Beyond metabolic regulation, obesity-related OSAS is closely linked to chronic low-grade systemic inflammation driven by intermittent hypoxia
Since hair loss is already a concern with rapid weight loss and GLP-1 therapy, maintaining zinc levels is one modifiable factor that can help mitigate this side effect
But it is important to remember that your bodys response to alcohol may be different while on the medication
The Journal of Clinical Endocrinology & Metabolism, 104 (11), 57035714
The cardioprotective effects of GLP-1RAs include anti-inflammatory actions, reduction of myocardial ischemia injury, modifications in the synthesis and secretion of lipids, and improvement of endothelial dysfunction (109)